Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CNC vs GSK✓SelectedUSD · GSKCNC vs GSK performance historyLatest closeAs of-2.97%11/17
Stock and ETF performance explorer

CNC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+95.7%
GSK return
+7.1%
Excess return
+88.5%
Maximum drawdown
-32.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.0%-2.3%-0.6%-2.7%
7D+3.4%-3.0%+6.4%+3.7%
30D+4.9%+0.4%+4.6%+4.8%
3M+12.6%-1.2%+13.8%+12.4%
6M+24.5%+0.9%+23.6%+24.4%
YTD+76.3%+4.0%+72.3%+67.8%
1Y+95.7%+7.3%+88.4%+80.2%
All+95.7%+7.1%+88.5%+80.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling